 BURNABY, British Columbia, June 03, 2021 GLOBE NEWSWIRE -- Xenon Pharmaceuticals Inc. Nasdaq:XENE, a neurology-focused biopharmaceutical company, provided a corporate update following its 2021 Annual Meeting of Shareholders the Annual Meeting held today on June 3, 2021. 